Shelly Kuhlmann, NP
Primary Care · Sandstone, MNNPI 1215797113
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Tempus AI, Inc at 24.3% of the total.
Across 11 payments — averaging $19.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tempus AI, Inc$52
- Boehringer Ingelheim$34
- Supernus Pharmaceuticals, Inc.$33
- Boston Scientific$18
- Teva Pharmaceuticals USA, Inc.$16
- AbbVie$16
- plus $46 from 3 others
What the payments were for
- Food & beverage$216100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tempus AI, Inc | 2 | $52 |
| Boehringer Ingelheim | 2 | $34 |
| Supernus Pharmaceuticals, Inc. | 1 | $33 |
| Boston Scientific | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| AbbVie | 1 | $16 |
| Phadia US Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
How this compares
$216 in reported general payments places this provider in the 65th percentile of 54 primary care providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 13 | $91 |
Paid to pharmacies, not to this prescriber.
Other primary care in Sandstone
- Manisha ShahEden Prairie$7K
- Lucy BrinkWillmar$4K
- Qiying SheCoon Rapids$2K
- Carmen VriezemaMinnetonka$2K
- Elizabeth LewisEdina$1K
- Laura BreuAitkin$1K
- Rhea Jane KetolaCoon Rapids$1K
- Sierra CashEdina$1K
- Khamal MisraRochester$720
- Cole OswaldSaint Cloud$678
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.